The Department of Veterans Affairs announced on May 27, 2026, that it is launching a trial to review the safety and efficacy of methylenedioxymethamphetamine (MDMA) assisted therapy for post-traumatic stress disorder (PTSD). The study will also examine the effects of MDMA on individuals with severe mental health disorders and alcohol use disorder.
✓ AI-Debiased Article
10
Wire-neutral
provisional
✓ No loaded language, vague sourcing, or framing detected.
VA Initiates Study on MDMA for Treating Veterans' PTSD
The Department of Veterans Affairs is starting a trial to assess MDMA assisted therapy for PTSD among veterans. The study will also investigate MDMA's impact on severe mental health disorders and alcohol use disorder.
Annotating as
No note attached
on this article.
Original vs. Neutral
Original Headline
VA studying MDMA as treatment for veterans’ PTSD
Neutral Headline
VA Initiates Study on MDMA for Treating Veterans' PTSD